Articles Posted in Elmiron

Elmiron is a prescription drug used by millions for the treatment of bladder conditions. In 2019, new research revealed that long-term use of Elmiron can cause permanent vision loss. This prompted thousands of Elmiron lawsuits which were consolidated into a class action MDL.

It has now been almost 2 years since the Elmiron class action lawsuit was formed. In this post, we will look at what has been going on in the Elmiron class action recently and speculate on when we could potentially see a global settlement.

About the Elmiron Lawsuits

Our lawyers handle Elmiron vision loss lawsuits throughout the country.

This page provides the latest news and updates on the Elmiron class action lawsuit and provides our prediction of the settlement amounts vision loss and blindness victims who bring an Elmiron lawsuit will ultimately receive. The conventional wisdom among Elmiron lawyers is that this class action lawsuit will settle in 2023.

Our atttorneys are reviewing these eye injury lawsuits. We think highly of these lawsuits and we think the settlement payouts offered by Janssen will be very high.

Our lawyers are handling Elmiron macular eye injury lawsuits in all 50 states alleging that victims’ macular degeneration was caused by the use of the drug for interstitial cystitis.

Elmiron is the brand name for pentosan polysulfate sodium, a prescription drug that is used by millions to treat a bladder condition called interstitial cystitis (IC).

In 2018, however, medical researchers discovered that prolonged use of Elmiron can cause some users to develop a new eye disease called pigmentary maculopathy which can result in vision impairment and blindness. Pigmentary maculopathy is only known to be caused by long-term use of pentosan polysulfate sodium.

Elmiron vision loss lawsuits are being filed at an increasing rate. Anyone that has been using the drug Elmiron to treat bladder conditions should be aware of the growing tide of concerns regarding the long-term side effects of this popular drug for interstitial cystitis.

After an initial wave of reports linking the use of Elmiron to serious vision impairment, the Food and Drug Administration (FDA) has recently stepped in and required the manufacturer of Elmiron to add a  new warning label.

The new warning label alerts doctors and patients that Elmiron may cause a rare eye disease called pigmentary maculopathy that can cause vision impairment or blindness. The new warning label comes just as Elmiron vision loss lawsuits are already being filed across the country. Ultimately, when an Elmiron class action settlement is reached down the road, I predict a strong, unambiguous black box warning of the side effects that include vision loss.

Contact Information